These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8304965)

  • 21. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of cyclooxygenase and signaling pathways involved in human platelet aggregation mediated by synergistic interaction of various agonists.
    Khan N; Farooq AD; Sadek B
    Drug Des Devel Ther; 2015; 9():3497-506. PubMed ID: 26185418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of single-dose aspirin on TXA2 and PGI2 cyclooxygenases in vivo.
    Zaragoza R; Le Breton GC
    Haemostasis; 1987; 17(1-2):40-8. PubMed ID: 3110025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thromboxane A2 synthase inhibition and thromboxane A2 receptor blockade by 2-[(4-cyanophenyl)amino]-3-chloro-1,4-naphthalenedione (NQ-Y15) in rat platelets.
    Chang TS; Kim HM; Lee KS; Khil LY; Mar WC; Ryu CK; Moon CK
    Biochem Pharmacol; 1997 Jul; 54(2):259-68. PubMed ID: 9271330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dipyridamole inhibits platelet aggregation induced by oxygen-derived free radicals.
    De la Cruz JP; García PJ; Sánchez de la Cuesta F
    Thromb Res; 1992 May; 66(4):277-85. PubMed ID: 1329255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of WEB 2086-BS, an antagonist of platelet-activating factor receptors, on retinal vascularity in diabetic rats.
    de la Cruz JP; Moreno A; Ruiz-Ruiz MI; García-Campos J; Sánchez de la Cuesta F
    Eur J Pharmacol; 1998 Oct; 360(1):37-42. PubMed ID: 9845270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial effects of a new potent and specific thromboxane receptor antagonist (SQ-29,548) in vitro and in vivo.
    Darius H; Smith JB; Lefer AM
    J Pharmacol Exp Ther; 1985 Nov; 235(2):274-81. PubMed ID: 2997428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling.
    Shah BH; Nawaz Z; Pertani SA; Roomi A; Mahmood H; Saeed SA; Gilani AH
    Biochem Pharmacol; 1999 Oct; 58(7):1167-72. PubMed ID: 10484074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclooxygenase inhibition, platelet function, and metabolite formation during chronic sulfinpyrazone dosing.
    Pedersen AK; FitzGerald GA
    Clin Pharmacol Ther; 1985 Jan; 37(1):36-42. PubMed ID: 3917387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro effect of mopidamol on platelet-subendothelium interaction.
    De La Cruz JP; Villalobos MA; Palacios R; Smith-Agreda JM; Sánchez de la Cuesta F
    Thromb Res; 1995 Jan; 77(1):97-103. PubMed ID: 7701482
    [No Abstract]   [Full Text] [Related]  

  • 31. Biochemical selectivity of oral versus intravenous aspirin in rats. Inhibition by oral aspirin of cyclooxygenase activity in platelets and presystemic but not systemic vessels.
    Cerletti C; Gambino MC; Garattini S; de Gaetano G
    J Clin Invest; 1986 Jul; 78(1):323-6. PubMed ID: 3088044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymeric inhibitors of platelet aggregation. II. Copolymers of dipyridamole and related drugs with N-vinylpyrrolidone.
    Bamford CH; Middleton IP; Al-Lamee KG
    Biochim Biophys Acta; 1987 Apr; 924(1):38-44. PubMed ID: 3828396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mechanism of action of KBT-3022, a new antiplatelet agent.
    Matsuo K; Yokota K; Yamashita A; Oda M
    Gen Pharmacol; 1997 Feb; 28(2):229-35. PubMed ID: 9013200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of a potent cyclooxygenase inhibitor, 5-ethyl-4-methoxy-2-phenylquinoline (KTC-5), on human platelets.
    Liao CH; Liao CH; Chang YL; Guh JH; Kuo SC; Huang LJ; Teng CM
    J Pharm Pharmacol; 2002 Jul; 54(7):967-74. PubMed ID: 12162716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of dipyridamole, nifedipine, verapamil, hydralazine and propranolol on the formation of prostacyclin and thromboxane in a coupled system of platelets and aorta.
    Srivastava KC
    Prostaglandins Leukot Med; 1986 Jul; 23(1):31-6. PubMed ID: 3090561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pyrimido-pyrimidine derivative RA-642 protects from brain injury in a combined model of permanent focal ischemia and global ischemia reperfusion.
    De La Cruz JP; Villalobos MA; Carrasco T; Smith-Agreda JM; Sánchez de la Cuesta F
    Brain Res; 1992 Dec; 597(2):250-6. PubMed ID: 1472997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Modification of metastasis formation by inhibition of platelet aggregation. Experimental and clinical results].
    Gastpar H
    Laryngol Rhinol Otol (Stuttg); 1983 Dec; 62(12):578-85. PubMed ID: 6369051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostacyclin production by rat aorta "in vitro" is increased by the combined action of dipyridamole plus pentoxifylline.
    Santos MT; Martinez-Sales V; Vallés J; Aznar J; Yaya R; Vayá A; Villa P
    Prostaglandins; 1985 Jan; 29(1):113-22. PubMed ID: 3919421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro.
    De Clerck F; Beetens J; de Chaffoy de Courcelles D; Freyne E; Janssen PA
    Thromb Haemost; 1989 Feb; 61(1):35-42. PubMed ID: 2546278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of action of dipyridamole.
    Harker LA; Kadatz RA
    Thromb Res Suppl; 1983; 4():39-46. PubMed ID: 6356465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.